Llwytho...
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
<p>Abstract</p> <p>Recently Byrski et al. reported the first-ever breast cancer (BC) study, which specifically selected BRCA1-carriers for the neoadjuvant treatment and used monotherapy by cisplatin instead of conventional schemes. Although the TNM staging of the recruited patients...
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2009-04-01
|
| Cyfres: | Hereditary Cancer in Clinical Practice |
| Mynediad Ar-lein: | http://www.hccpjournal.com/content/7/1/8 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|